Updates in Diagnosis of PTCL and the Role of CD30

Updates in Diagnosis of PTCL and the Role of CD30

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 10/20/2020

Max Credits: 0.25

View Activity

Options for Relapsed/Refractory PTCL

Options for Relapsed/Refractory PTCL

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 10/20/2020

Max Credits: 0.5

View Activity

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

The treatment paradigm for the management of patients with advanced cancer…

Expiration Date: 7/7/2020

Max Credits: 0

View Activity

Oncology Consults: The Latest on the Biosimilar Revolution

Oncology Consults: The Latest on the Biosimilar Revolution

Several of the most-used cancer drugs are biologics and many, including ri…

Expiration Date: 6/27/2020

Max Credits: 0

View Activity

2019 Texas Oncology Clinical Educational Symposium

2019 Texas Oncology Clinical Educational Symposium

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 6/27/2020

Max Credits: 0

View Activity

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

Multigene assays that evaluate an array of prognostic and/or predictive mo…

Expiration Date: 6/10/2020

Max Credits: 0

View Activity

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly dia…

Expiration Date: 6/10/2020

Max Credits: 0

View Activity

Updates in Hepatocellular Carcinoma: Clinical Decision-making Among an Array of New Options

Updates in Hepatocellular Carcinoma: Clinical Decision-making Among an Array of New Options

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide a…

Expiration Date: 5/23/2020

Max Credits: 0

View Activity

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 0

View Activity